$AUID
authID Inc. Stock $auid

$auid Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024043594 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$300.0K	$157.4K	$37.86K
YoY Change	650.0%	315.73%	-77.06%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.169M	$2.062M	$3.276M
YoY Change	12.73%	-37.05%	-26.85%
% of Gross Profit
Research & Development	$1.392M	$1.205M	$1.106M
YoY Change	74.82%	8.97%	105.6%
% of Gross Profit
Depreciation & Amortization	$44.00K	$43.41K	$76.02K
YoY Change	-42.12%	-42.9%	-68.8%
% of Gross Profit
Operating Expenses	$3.605M	$3.311M	$4.458M
YoY Change	28.92%	-25.74%	-14.81%
Operating Profit	-$3.325M	-$3.153M	-$4.420M
YoY Change	20.49%	-28.66%	-12.78%
Interest Expense	$63.59K	$95.78K	$223.0K
YoY Change	-122.54%	-57.05%	-743.76%
% of Operating Profit
Other Income/Expense, Net	$63.59K	$95.78K	$0.00
YoY Change	-99.15%		-100.0%
Pretax Income	-$3.261M	-$3.058M	-$5.220M
YoY Change	-70.07%	-41.43%	2.37%
Income Tax
% Of Pretax Income
Net Earnings	-$3.261M	-$3.058M	-$5.222M
YoY Change	-69.46%	-41.45%	-1.48%
Net Earnings / Revenue	-1087.08%	-1942.82%	-13795.68%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.34	-$0.32	-$0.21
COMMON SHARES
Basic Shares Outstanding	9.450M shares	9.450M shares	25.03M shares
Diluted Shares Outstanding	9.502M shares	9.450M shares	25.33M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.41M	$7.226M	$1.588M
YoY Change	140.85%	355.06%	-88.49%
Cash & Equivalents	$14.41M	$7.226M	$1.588M
Short-Term Investments
Other Short-Term Assets	$771.8K	$485.6K	$425.0K
YoY Change	-0.15%	14.25%	-31.9%
Inventory
Prepaid Expenses
Receivables	$192.7K	$328.8K	$55.39K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$15.73M	$8.251M	$2.133M
YoY Change	131.43%	286.81%	-85.78%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$4.183M	$4.183M	$4.183M
YoY Change	0.0%	0.0%
Intangibles	$255.2K	$283.6K	$490.2K
YoY Change	-38.4%	-42.15%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.438M	$4.467M	$4.697M
YoY Change	-3.46%	-4.9%	-32.08%
TOTAL ASSETS
Total Short-Term Assets	$15.73M	$8.251M	$2.133M
Total Long-Term Assets	$4.438M	$4.467M	$4.697M
Total Assets	$20.17M	$12.72M	$6.830M
YoY Change	77.01%	86.2%	-68.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$494.5K	$239.4K	$666.7K
YoY Change	-43.23%	-64.09%	-3.83%
Accrued Expenses	$828.6K	$666.9K	$1.205M
YoY Change	130.36%	-44.65%	-0.62%
Deferred Revenue	$240.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$232.7K	$228.5K
YoY Change
Total Short-Term Liabilities	$1.846M	$1.526M	$1.963M
YoY Change	43.13%	-22.28%	-33.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$8.443M
YoY Change	-100.0%	-100.0%	13.11%
Other Long-Term Liabilities	$0.00	$325.0K	$325.0K
YoY Change	-100.0%	0.0%
Total Long-Term Liabilities	$0.00	$325.0K	$8.768M
YoY Change	-100.0%	-96.29%	17.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.846M	$1.526M	$1.963M
Total Long-Term Liabilities	$0.00	$325.0K	$8.768M
Total Liabilities	$1.846M	$1.851M	$10.73M
YoY Change	0.82%	-82.75%	2.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$165.8M	-$162.6M	-$145.4M
YoY Change	6.28%	11.87%
Common Stock	$184.2M	$173.4M	$2.587K
YoY Change	23430654.45%	6704137.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.32M	$10.87M	-$3.901M
YoY Change
Total Liabilities & Shareholders Equity	$20.17M	$12.72M	$6.830M
YoY Change	77.01%	86.2%	-68.84%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.261M	-$3.058M	-$5.222M
YoY Change	-69.46%	-41.45%	-1.48%
Depreciation, Depletion And Amortization	$44.00K	$43.41K	$76.02K
YoY Change	-42.12%	-42.9%	-68.8%
Cash From Operating Activities	-$2.800M	-$2.948M	-$2.170M
YoY Change	39.99%	35.83%	-30.04%
INVESTING ACTIVITIES
Capital Expenditures	$15.58K	$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$15.58K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00M		$543.8K
YoY Change	56.67%		-94.98%
NET CHANGE
Cash From Operating Activities	-$2.800M	-$2.948M	-$2.170M
Cash From Investing Activities	-15.58K	0.000
Cash From Financing Activities	10.00M		$543.8K
Net Change In Cash	-$2.800M	-$2.951M	-$1.649M
YoY Change	-163.88%	78.97%	-121.34%
FREE CASH FLOW
Cash From Operating Activities	-$2.800M	-$2.948M	-$2.170M
Capital Expenditures	$15.58K	$0.00	$0.00
Free Cash Flow	-$2.816M	-$2.948M	-$2.170M
YoY Change	40.77%	35.83%	-30.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3180538	shares
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.32
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40747
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	authID Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2069547
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1580 North Logan Street
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 660, Unit 51767
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80203
CY2024Q1	dei	City Area Code CityAreaCode	516
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	274-8700
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	AUID
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9450220	shares
CY2024Q1	us-gaap	Cash Cash	7226212	usd
CY2023Q4	us-gaap	Cash Cash	10177099	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	328782	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91277	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	160718	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	157300	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	485598	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	476004	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	49713	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	8251023	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10901680	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	283593	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	327001	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4183232	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4183232	usd
CY2024Q1	us-gaap	Assets Assets	12717848	usd
CY2023Q4	us-gaap	Assets Assets	15411913	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	906244	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1408965	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	307647	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	131628	usd
CY2024Q1	auid	Commission Liability CommissionLiability	83200	usd
CY2023Q4	auid	Commission Liability CommissionLiability	124150	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	228539	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1525630	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1664743	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	224424	usd
CY2024Q1	auid	Accrued Severance Liability AccruedSeveranceLiability	325000	usd
CY2023Q4	auid	Accrued Severance Liability AccruedSeveranceLiability	325000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1850630	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2214167	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9450220	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9450220	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9450220	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9450220	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	945	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	945	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	173437683	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	172714712	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-162588112	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159530535	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16702	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12624	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	10867218	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13197746	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12717848	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15411913	usd
CY2024Q1	us-gaap	Revenues Revenues	157378	usd
CY2023Q1	us-gaap	Revenues Revenues	37856	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2062361	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	822755	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1204968	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	120638	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43408	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76017	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3310737	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1019410	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3153359	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-981554	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	13138	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	800073	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	108920	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	95782	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-800073	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3057577	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1781627	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3057577	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1781627	usd
CY2023Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-2255	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3057577	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1783881	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.32
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.56
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9450220	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3180538	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3057577	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1783881	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4078	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-24066	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3053499	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1807947	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	283536	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-2598592	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	222427	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1783881	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-24066	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-3900576	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13197746	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	722971	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3057577	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4078	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	10867218	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3057577	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1783881	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	722971	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-2598592	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43408	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76017	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4115	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	567287	usd
CY2023Q1	auid	Noncash Recruiting Fees NoncashRecruitingFees	492000	usd
CY2023Q1	auid	Shares Issued In Lieu Of Interest SharesIssuedInLieuOfInterest	222427	usd
CY2023Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	8250	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	237506	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-206419	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-44368	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	59233	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-106600	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-495357	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	155371	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	176019	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7449	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	325000	usd
CY2023Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	60494	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2947528	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2170057	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	543760	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	543760	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3359	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-22505	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2950887	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1648802	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10177099	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3237106	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	2703	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	3025	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7226212	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1587982	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9023	usd
CY2023Q1	auid	Cash Paid For Income Taxes Discontinued Operations CashPaidForIncomeTaxesDiscontinuedOperations	1294	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-162600000	usd
CY2024Q1	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	-160000	usd
CY2024Q1	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	-2900000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3100000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Reclassification</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, we reclassified approximately $19,000 in Q1 2023 expenses from research and development expenses to general and administrative expenses.</p>
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	19000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2487515	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1455148	shares
CY2024Q1	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Revenue Recognition</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Verified Software License </i>– The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had deferred revenue contract liabilities of approximately $308,000 and $132,000 as of March 31, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of March 31, 2024 are expected to be earned over the next twelve months.</p>
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	308000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	132000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4030000.00	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	310000	usd
CY2024Q1	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	3730000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.40	pure
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	157300	usd
CY2024Q1	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	5850	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2432	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	160718	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	73797	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	184492	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	411801	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	291512	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	485598	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	476004	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	327001	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43408	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	283593	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1899276	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1615683	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	283593	usd
CY2024Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	43000	usd
CY2023Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	76000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	130224	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	69328	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	19230	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	16461	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	16461	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	31889	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	283593	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax		usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	239376	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	339832	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	412965	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	707317	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	253903	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361816	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	906244	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1408965	usd
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	163000	usd
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7874962	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7874962	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.23	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1796743	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.56
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9450220	shares
CY2024Q1	auid	Noncash Recruiting Fees NoncashRecruitingFees		usd
CY2024Q1	auid	Shares Issued In Lieu Of Interest SharesIssuedInLieuOfInterest		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.2
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3630733	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.38
CY2024Q1	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P10Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15772	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.35
CY2024Q1	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Forfeitedcancelled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeForfeitedcancelled	P4Y3M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1880971	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.23
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2163663	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1158568	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	30.57
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1085676	usd
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1880971	shares
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1158568	shares
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	5000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2024Q1	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities		usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2024Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations		usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	auid	Cash Paid For Income Taxes Discontinued Operations CashPaidForIncomeTaxesDiscontinuedOperations		usd
CY2024Q1	auid	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGrantDateIntrinsicValue		usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeExercised
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2024Q1	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Forfeitedcancelled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueForfeitedcancelled		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001534154

Files In Submission

Name	View Source	Status
0001213900-24-043594-index-headers.html	Edgar Link	pending
0001213900-24-043594-index.html	Edgar Link	pending
0001213900-24-043594.txt	Edgar Link	pending
0001213900-24-043594-xbrl.zip	Edgar Link	pending
auid-20240331.xsd	Edgar Link	pending
ea0205258-10q_authid.htm	Edgar Link	pending
ea020525801ex31-1_authidinc.htm	Edgar Link	pending
ea020525801ex31-2_authidinc.htm	Edgar Link	pending
ea020525801ex32-1_authidinc.htm	Edgar Link	pending
ea020525801ex99-1_authidinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
auid-20240331_cal.xml	Edgar Link	unprocessable
auid-20240331_def.xml	Edgar Link	unprocessable
auid-20240331_lab.xml	Edgar Link	unprocessable
auid-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205258-10q_authid_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUID
authID Inc. Stock $auid

2024 Q2 Form 10-Q Financial Statement

#000121390024043594 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUID authID Inc. Stock $auid

2024 Q2 Form 10-Q Financial Statement

#000121390024043594 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUID
authID Inc. Stock $auid